Navigation Links
Mary Matalin and John Ray Join the Cheney Cardiovascular Institute Board of Directors

WASHINGTON, March 27 /PRNewswire-USNewswire/ -- The Richard B. and Lynne V. Cheney Cardiovascular Institute today announced that Mary Matalin and John Ray have joined the Institute's Board of Directors. As directors, they will help shape strategic direction for the Institute.

"Mary Matalin's experience in public affairs and media will be a valued addition to the Institute as we build our organization and educate communities nationwide about the research, education and outreach work of the Institute. Her voice will amplify our messages and be invaluable in connecting the Institute to larger medical and public communities. We also remain absolutely committed to the Washington, DC community and as a respected leader in the Washington, DC community, the Honorable John Ray will bring to the Institute the knowledge and support needed to launch our community outreach efforts," said Dr. Richard J. Katz, Director of the Institute and Director of the Division of Cardiology.

Mary Matalin has experience in politics, public affairs, and media that spans three decades and multiple presidents. She has served Presidents Reagan, George H. W. Bush and George W. Bush, and joined the current administration in the first term as Assistant to the President and Counselor to the Vice President. She served as senior advisor on major initiatives, including national security, homeland security, energy, economic growth and corporate governance policies. Matalin is currently Editor-in-Chief of Threshold Editions, an imprint of Simon & Schuster and First Vice President of Washington Humane Society. She also makes frequent television appearances as a political commentator.

John Ray is a partner at Manatt, Phelps & Phillips, LLP, the national law and consulting firm, and represents clients in their relations with the United States Government and with state and local governments. He also provides legal counsel in healthcare, banking, telecommunications, real estate, land use, historic preservation and general corporate law. Ray's involvement in local, national and international affairs and the political processes of Washington spans the past 27 years. He has a long record of leadership in Democratic Party activities. Ray served as an at-large member of the District of Columbia City Council for eighteen years.


The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006. The Institute's mission is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. For more information, please visit:

SOURCE The Cheney Cardiovascular Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Nurses Launch National CheneyCare Campaign
2. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
3. Medical Simulation Corporation to Present Comprehensive Cardiac Patient Scenario at the Society for Cardiovascular Angiography and Interventions (SCAI) and American College of Cardiology (ACC) Conference
4. Study finds certain liver disease related to cardiovascular fitness
5. Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease
6. Cardiovascular nursing: Striving for excellence in the care of cardiac patients
7. Glaucoma May Boost Cardiovascular Death Risk in Blacks
8. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
9. Led by Cardiovascular Applications, Double Digit Growth Expected for Catheter Sales
10. Randy Jackson and the American Heart Association Educate Minneapolis Area about the Connection between Type 2 Diabetes and Cardiovascular Disease
11. Randy Jackson and the American Heart Association Educate Cincinnati Area Residents about the Connection between Type 2 Diabetes and Cardiovascular Disease
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... Using a combination ... prediabetes in American children and adults, according to a new study by researchers at ... of Prediabetes in Children and Adults: Using Combinations of Blood Glucose Tests ,” published ...
(Date:11/30/2015)... VA (PRWEB) , ... November 30, 2015 , ... ... Association of Poison Control Centers’ National Poison Data System (NPDS) reveals that in ... managed almost 3 million cases, over two million of which were human exposure ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... (ASI) as their exclusive channel partner for the Nutraceutical Specialties products into oral ... the US, effective immediately. , “We are pleased to announce our expanded ...
(Date:11/30/2015)... Chicago, Ill. (PRWEB) , ... November 30, 2015 ... ... and Decision Support Solutions, announced at the Radiology Society of North America (RSNA) ... bookings have seen over 60% growth from 2014. Throughout 2015, the company ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Kreithen”), one of the leading plastic surgery practices in Florida, is proud to ... to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOSTON , Nov. 30, 2015  Kevin ... of Sensium Healthcare, a global pioneer in wireless ... Boston, MA , Mr. Smith ... of Sensium,s global commercial strategy.  He will also ... universities, to build clinical evidence for SensiumVitals, the ...
(Date:11/30/2015)... , Nov. 30, 2015  The fee-for-service ... in U.S. medical imaging is on its ... accountable care payer-provider contracts are set to ... their wake, alter provider-vendor relationships. The shift ... push forward new purchasing frameworks in the ...
(Date:11/30/2015)... WOODCLIFF LAKE, N.J. and SAN ... Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... (FDA) has accepted for filing the New Drug Application ... approved, the extended release formulation will offer patients a ... ® ) is currently approved as ...
Breaking Medicine Technology: